Tacrolimus (also known by the brand names Prograf and Advagraf) is an immunosuppressant medication used to prevent organ rejection after transplantation. It works by suppressing the body's immune system so it will not attack a transplanted organ. Tacrolimus was approved by the US Food and Drug Administration (FDA) in 1994 for use in kidney, heart, and liver transplants. It is often prescribed in conjunction with other forms of medication.
Tacrolimus can also be used in skin conditions like atopic dermatitis, psoriasis, and lichen planus along with autoimmune diseases like rheumatoid arthritis and Crohn's disease.
Tacrolimus is supplied under its generic name or the brand names Astagraf XL, Envarsus XR, and Prograf.



